InspireMD Announces Inventory Exchange Listing Transfer to Nasdaq
3 min readTicker to stay NSPR
TEL AVIV, Israel, May perhaps 10, 2021 (Globe NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Avoidance Method (EPS) for the prevention of stroke triggered by the remedy of Carotid Artery Illness (CAD), now introduced the Company’s shares have been authorized for listing on The Nasdaq Cash Market place (“Nasdaq”). Trading is anticipated to commence on May 21, 2021, underneath the symbol NSPR on the Nasdaq.
InspireMD CEO Marvin Slosman commented, “We believe that that going to the Nasdaq Money Industry is a strategically critical adjust that locations us in the company of our friends and allows us higher obtain to a broader established of investors, thus enabling us to create our fundamental foundation of traders. InspireMD is a more robust enterprise now than ever right before, and I am proud of the extraordinary endeavours of our expanding group in making an thrilling future for our corporation. We are really happy to now be a portion of the Nasdaq trade and price our new relationship.”
About InspireMD, Inc.
InspireMD seeks to use its proprietary MicroNet® technological innovation to make its items the sector typical for carotid stenting by offering remarkable acute success and sturdy, stroke-absolutely free, lengthy-expression results.
As of May perhaps 21, 2021, InspireMD’s frequent stock will be quoted on the Nasdaq underneath the ticker symbol NSPR.
Ahead-searching Statements
This push launch is made up of “forward-searching statements.” This kind of statements may perhaps be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or comparable words. Forward-on the lookout statements are not assures of long term performance, are based mostly on sure assumptions and are issue to different recognized and not known threats and uncertainties, lots of of which are outside of the Company’s management, and can not be predicted or quantified and for that reason, genuine results may well differ materially from these expressed or implied by these kinds of ahead-wanting statements. These types of challenges and uncertainties contain, with no limitation, pitfalls and uncertainties associated with (i) market place acceptance of our existing and new products, (ii) negative clinical demo success or lengthy product delays in vital markets, (iii) an lack of ability to safe regulatory approvals for the sale of our products, (iv) powerful levels of competition in the medical product marketplace from a lot greater, multinational firms, (v) product or service liability claims, (vi) product or service malfunctions, (vii) our limited production abilities and reliance on subcontractors for support, (viii) inadequate or inadequate reimbursement by governmental and other 3rd party payers for our merchandise, (ix) our attempts to properly get hold of and maintain intellectual property safety masking our goods, which could not be thriving, (x) legislative or regulatory reform of the healthcare technique in each the U.S. and overseas jurisdictions, (xi) our reliance on solitary suppliers for sure product components, (xii) the fact that we will need to elevate more funds to fulfill our organization necessities in the potential and that this sort of cash boosting may perhaps be costly, dilutive or challenging to receive and (xiii) the reality that we conduct organization in numerous foreign jurisdictions, exposing us to overseas currency exchange level fluctuations, logistical and communications problems, burdens and expenditures of compliance with overseas guidelines and political and financial instability in each and every jurisdiction. Far more comprehensive info about the Organization and the danger variables that may well have an impact on the realization of ahead-wanting statements is established forth in the Company’s filings with the Securities and Trade Commission (SEC), like the Company’s Annual Report on Kind 10-K and its Quarterly Studies on Type 10-Q. Investors and safety holders are urged to browse these files free of cost on the SEC’s internet web site at http://www.sec.gov. The Enterprise assumes no obligation to publicly update or revise its forward-searching statements as a outcome of new information and facts, long term events or if not.
Trader Contacts:
Craig Shore
Chief Economical Officer
InspireMD, Inc.
888-776-6804
[email protected]
Core IR
[email protected]
